Chemotherapy of gastric cancer

Publisher Website
Google Scholar
Abstract
Summary Background Until recently, chemotherapy of gastric cancer was regarded as only marginally active when used with palliative intention or perioperatively. Methods This is a critical review of the chemotherapy trials being published in gastric carcinoma since 1980. Results During the past 10 years a number of new and active combinations had been developed, which induced 40 to 60% of objective remissions (mostly in phase-II-trials) and up to 10% of clinically complete remissions (in part pathologically confirmed) in locally advanced or metastasized tumors. With these regimens, median survival times of 9 to 11 months were achieved. Moreover, it was shown that a chemotherapy induced reduction of local tumor spread may allow R0-resection of primarily irresectable disease and that chemotherapy can be also used with curative intention. Conclusions Because of these results, gastric cancer can be regarded as a chemosensitive tumor.

This publication has 0 references indexed in Scilit: